STEP-BY-STEP ANSWER:
Step 1: Distinguish between beta-1 and beta-2 adrenergic receptors – beta-1 receptors are primarily located in the heart, while beta-2 receptors are found in the lungs and vasculature.
Step 2: Understand that beta blockers with high beta-1 selectivity primarily affect cardiac tissue, reducing heart rate and myocardial contractility.
Step 3: Recognize that this selectivity minimizes unwanted side effects in other tissues (like bronchoconstriction in the lungs).
Step 4: Conclude that selective beta blockers are preferable in patients with concurrent respiratory issues.
Final Answer: Receptor selectivity in beta blockers ensures targeted cardiac effects and minimizes adverse effects on other organs, enhancing clinical safety and efficacy in managing heart conditions.